HGF/C-Met Expression in Epithelial Ovarian Carcinogenesis and Its Potential as Molecular Targeted Therapy

Background: The Mesenchymal-Epithelial Transition factor (C-Met) is a tyrosine kinase receptor (TKR) that binds to a ligand called Hepatocyte Growth Factor (HGF). Recent studies conducted on patients with epithelial ovarian cancer (EOC) reported that high expression of C-Met was associated with poor...

תיאור מלא

מידע ביבליוגרפי

Principais autores:	Angeline Maranata, Tantri Hellyanti, Ria Kodariah
פורמט:	Artigo
שפה:	Inglês
יצא לאור:	Dharmais Cancer Hospital - National Cancer Center 2023-09-01
סדרה:	Indonesian Journal of Cancer
נושאים:	epithelial ovarian carcinoma hgf c-met targeted therapy
גישה מקוונת:	https://www.indonesianjournalofcancer.or.id/e-journal/index.php/ijoc/article/view/1047
תגים:	הוספת תג אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!